大规模临床试验中心脏综合结果的挑战
Ravi B Patel1, Jozine M Ter Maaten2, João Pedro Ferreira3
1Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL (R.B.P., S.J.S.).
Circulation
|January 7, 2021
概括
新的治疗方法如SGLT2抑制剂和sacubitril-valsartan对心脏和脏健康都有好处. 未来的试验可能会使用心脏和结合的结果,但需要解决一些挑战.
科学领域:
- 心脏病学
- 肝脏病学
- 药理学
背景情况:
- 心血管和脏疾病经常同时存在,使患者的病情恶化.
- 心力衰竭和功能障碍的临床表现可能会重叠,使诊断复杂化.
- 现有治疗方法对心脏和脏健康有两种好处.
研究的目的:
- 审查新疗法对心脏结局的影响.
- 讨论在临床试验中使用复合心脏-结点的潜力和挑战.
主要方法:
- 对最近的临床试验数据和后期分析的审查.
- 对SGLT2抑制剂和sacubitril-valsartan的证据的检查.
- 对综合性心脏结果测量方法的理由和挑战的分析.
主要成果:
- 在慢性病,心血管疾病和心力衰竭中,SGLT2 抑制剂具有益处.
- 在心力衰竭中,萨库比特-瓦尔萨坦改善了心血管结果,并显示出有利的效应.
- 证据表明这些新药对心脏和脏有相应的益处.
结论:
- 新型疗法对心血管和脏健康有两大好处.
- 综合性心脏-结局正在考虑未来的试验.
- 在实施复合心脏结点之前,需要仔细考虑挑战.
相关概念视频
Chronic Kidney Disease II: Clinical Manifestations
353
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
353
Chronic Kidney Disease III: Interprofessional Care
206
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
206
Acute Kidney Injury IV: Diagnostic Studies and Prevention
139
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
139
Chronic Kidney Disease IV: Nursing Management
154
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
154
Kidney Transplant I: Introduction
158
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
158
Acute Kidney Injury III: Clinical Manifestations
452
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
452


